“Trojan peptide” vaccine turns body against cancer

Published



A possible cure for some types of mouth, larynx and throat cancer is being tested at the University of Maryland Medical Center.

University researchers have begun testing “Trojan peptide” vaccines to treat squamous cell carcinoma, a common type of head and neck cancer. The vaccine targets specific proteins made by tumors, and in theory can stimulate the body?s immune system to destroy the cancer.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.